Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, and Single-cell and spatial transcriptomics.
Unmasking: paronychia as the hidden face of pemphigus.
Milk and honey: how skin changes reveal the deeper dangers of nutritional deficiencies.
Novel Identical Likely Pathogenic ACTB Variant in Congenital Smooth Muscle Hamartoma: A Report of Two Pediatric Cases.
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis.
Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
Activated T Cells Break Tumor Immunosuppression by Macrophage Reeducation
Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype.
Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma
Activated T Cells Break Tumor Immunosuppression by Macrophage Reeducation.
Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionals
Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma.
Travelers From the Intestine to the Skin: A Useful Clue to Diagnose a Cryptic Histoplasma Infection.
The normal human lymph node cell classification and landscape defined by high-dimensional spatial proteomics
Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionals.
A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma
A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma.
A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma
A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6<sup>high</sup> uterine leiomyosarcoma to PD‐1 blockade
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6<sup>high</sup> uterine leiomyosarcoma to PD-1 blockade.
Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis
The Clinical Relevance of the Infiltrating Immune Cell Composition in Kidney Transplant Rejection.
Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis.
An autophagy program that promotes T cell egress from the lymph node controls responses to immune checkpoint blockade.
Simple generation of cleavable labels for multiplexed imaging.
Dissecting the immune infiltrate of primary luminal B-like breast carcinomas in relation to age.
Recent advancements in tumour microenvironment landscaping for target selection and response prediction in immune checkpoint therapies achieved through spatial protein multiplexing analysis.
Author Correction: A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours
CD4<sup>+</sup> T cell-induced inflammatory cell death controls immune-evasive tumours.